Basics Glaukos Corporation Glaukos Corp is an ophthalmic medical technology company focused on the development and commercialization of breakthrough products and procedures designed to transform the treatment of glaucoma. IPO Date: June 25, 2015 Sector: Healthcare Industry: Medical Instruments and Equipment Market Cap: $6.23B Activated in VL: True Average Daily Range Avg Daily Range: $1.15 | 2.03% Avg Daily Range (30 D): $1.96 | 2.17% Avg Daily Range (90 D): $1.84 | 2.07% Institutional Daily Volume Avg Daily Volume: .48M Avg Daily Volume (30 D): 1.1M Avg Daily Volume (90 D): .93M Trade Size Avg Trade Size (Sh.): 69 Avg Trade Size (Sh.) (30 D): 52 Avg Trade Size (Sh.) (90 D): 50 Institutional Trades Total Inst.Trades: 5,934 Avg Inst. Trade: $3M Avg Inst. Trade (30 D): $4.41M Avg Inst. Trade (90 D): $4.45M Avg Inst. Trade Volume: .04M Avg Inst. Trades (Per Day): 2 Market Closing Trades Avg Closing Trade: $4.31M Avg Closing Trade (30 D): $11.95M Avg Closing Trade (90 D): $10.67M Avg Closing Volume: 60.43K     News Sep 4, 2025 @ 5:30 AM Nicox prévoit de rembourser intégralement se... Source: Nicox Sa Sep 4, 2025 @ 5:30 AM Nicox Expects to Fully Repay Financial Debts with ... Source: Gavin Spencer Sep 11, 2024 @ 6:20 PM Glaukos Stocks Rides on Strong Product Demand Amid... Source: Zacks Jul 16, 2024 @ 2:30 PM Will WATCHMAN Sales Aid Boston Scientific's (BSX) ... Source: N/A Jul 16, 2024 @ 2:06 PM Truist lifts Glaukos shares target, highlights str... Source: Emilio Ghigini Financials   TTM Q3 2025 Q2 2025 Basic EPS $-1.53 $-.28 $-.34 Diluted EPS $-1.53 $-.28 $-.34 Revenue $ 469.82M $ 133.54M $ 124.12M Gross Profit $ 361.14M $ 104.71M $ 97.22M Net Income / Loss $ -87.61M $ -16.23M $ -19.66M Operating Income / Loss $ -88.4M $ -16.37M $ -22.69M Cost of Revenue $ 108.68M $ 28.83M $ 26.9M Net Cash Flow $ -1.49M $ -8.82M $ -11.56M PE Ratio